| Market revenue in 2025 | USD 95.7 million |
| Market revenue in 2033 | USD 390.3 million |
| Growth rate | 19.2% (CAGR from 2026 to 2033) |
| Largest segment | Software |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Services |
| Key market players worldwide | Certara Inc Ordinary Shares, Dassault Systemes SE, Avantium NV, Simulations Plus Inc, Schrodinger Inc Ordinary Shares, Chemical Computing Group, Physiomics, Rosa & Co, Genedata AG, Instem, Yokogawa Electric Corp., Immunetrics |
Canada is anticipated to witness lucrative market growth owing to the rising need for developing new generation therapeutics at relatively lower costs. Encouragement from private and public organizations to incorporate advanced drug development techniques is fueling the market growth in Canada.
For instance, Genome Canada organized Bioinformatics and Computational Biology Competition in 2012 in partnership with Canadian Institutes of Health Research (CIHR). Through this initiative, 17 projects across the country received funding.
Consequentially, this is anticipated to increase the market share and intensify price competition in the country. These factors are expected to create lucrative growth opportunities in Canada in the near future.
Publish Date: May 29, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Certara Inc Ordinary Shares | View profile | 1,391 | 100 Overlook Center, Suite 101, Princeton, NJ, United States, 08540 | www.certara.com |
| Dassault Systemes SE | View profile | 23,811 | 10, Rue Marcel Dassault, Velizy-Villacoublay, France, 78140 | www.3ds.com |
| Avantium NV | View profile | 249 | Zekeringstraat 29-31, Amsterdam, Netherlands, 1014 BV | www.avantium.com |
| Simulations Plus Inc | View profile | 197 | 42505 Tenth Street West, Lancaster, CA, United States, 93534-7059 | www.simulations-plus.com |
| Schrodinger Inc Ordinary Shares | View profile | 787 | 1540 Broadway, 24th Floor, New York, NY, United States, 10036 | www.schrodinger.com |
| Chemical Computing Group | View profile | 11-50 | Montreal, Quebec, Canada, North America | www.chemcomp.com |
| Physiomics | View profile | 11-50 | Oxford, Oxfordshire, United Kingdom, Europe | www.physiomics-plc.com/ |
| Rosa & Co | View profile | 11-50 | San Carlos, California, United States, North America | www.rosaandco.com |
| Genedata AG | View profile | 51-100 | Basel, Basel-Stadt, Switzerland, Europe | www.genedata.com/ |
| Instem | View profile | 51-100 | Conshohocken, Pennsylvania, United States, North America | www.instem.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biosimulation Market Outlook will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 70.11% in 2025.
Horizon Databook has segmented the Canada biosimulation market based on software, services covering the revenue growth of each sub-segment from 2021 to 2033.
Canada is anticipated to witness lucrative market growth owing to the rising need for developing new generation therapeutics at relatively lower costs. Encouragement from private and public organizations to incorporate advanced drug development techniques is fueling the market growth in Canada.
For instance, Genome Canada organized Bioinformatics and Computational Biology Competition in 2012 in partnership with Canadian Institutes of Health Research (CIHR). Through this initiative, 17 projects across the country received funding.
Consequentially, this is anticipated to increase the market share and intensify price competition in the country. These factors are expected to create lucrative growth opportunities in Canada in the near future.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada Biosimulation Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Canada Biosimulation Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
